庆祝上市 全新改版

Re:【medical-news】房颤导管和外科消融的新指南公布

New guidelines on catheter and surgical ablation for AF unveiled
房颤导管和外科消融的新指南公布
10 May 2007

MedWire News: The first international consensus statement on catheter and surgical ablation techniques to treat atrial fibrillation (AF) has been released at the 28th annual meeting of the US Heart Rhythm Society (HRS) in Denver, Colorado.
MedWire新闻:在科罗拉多州丹佛市举行的第28界美国心脏节律协会(HRS)年会上,科学家们发布了第一个国际性一致同意的关于导管和外科消融技术治疗房颤(AF)的声明。
The statement aims to improve patient care by providing physicians with a comprehensive review of the techniques in AF. Studies have shown that three-quarters of patients with AF receive inappropriate care.
这个声明的的目的是为医师综合性回顾房颤治疗的技术,以便于改善病人的治疗。研究显示四分之三的房颤病人接受了不适宜的治疗。
“These guidelines are a major step toward helping physicians provide better, safer, and more consistent care for heart patients worldwide,” said chair of the HRS scientific and clinical guidelines committee Hugh Calkins, from Johns Hopkins University in Baltimore, Maryland, USA.
“这些指南是帮助医师为全球范围内的心脏病人提供更好,更安全,更适宜的治疗”心脏节律协会医学科学和临床指南委员会主席,来自美国马里兰州Baltimore市Johns Hopkins医院的Hugh Calkins说到。
The statement was developed by a Task Force convened by the HRS that includes international heart rhythm specialists representing the American Heart Association, the European Heart Rhythm Association, the European Cardiac Arrhythmia Society, and the Society of Thoracic Surgeons HRS.
心脏节律协会召集了包括代表美国心脏协会的国际心律专家,欧洲心律协会,欧洲心律失常分会和心脏节律协会心胸外科分会等调查单位共同发表了以上声明。
It stresses that, since ablation of AF is more complicated than other ablation procedures, training should encompass six fundamental principles: appropriate selection of patients; knowledge of the anatomy of the atria and adjacent structures; conceptual knowledge of strategies to ablate AF; technical competence; recognition, prevention, and management complications; and appropriate follow-up and long-term management.
声明强调了:因为房颤消融比其他消融过程更复杂,所以训练必须包含6个基本原则:合适病人的选择;心房及其邻近解剖结构的知识;房颤消融策略的概念上的知识;能胜任的技术;识别,预防和处理并发症;适当的随访和长期管理。
Of note, the primary indication for catheter ablation of AF is the presence of symptomatic AF refractory or intolerant to at least one Class 1 or Class 3 anti-arrhythmic medication. It may rarely be considered as first-line therapy.
房颤导管消融的基本适应症是存在难治性房颤的症状,或者至少对一种第1类或第3类抗心律失常药耐药。这可能很少被认为是首要的治疗。
The Task Force states that catheter ablation of AF is also appropriate in selected symptomatic patients with heart failure and/or reduced ejection fraction. In contrast, catheter ablation as an alternative to long-term anticoagulation is not appropriate, and left atrial thrombus is a contraindication, it says.
调查单位认为房颤导管消融同样适用于心衰和/或射血分数降低的选择性症状性病人。
Meanwhile, surgical AF ablation is indicated for symptomatic AF patients undergoing other cardiac surgery; selected asymptomatic patients undergoing cardiac surgery in whom the ablation carries minimal risk; and stand-alone surgery in symptomatic AF patients who prefer a surgical approach, have failed previous catheter ablation attempts, or are not candidates for catheter ablation.
同时,外科房颤消融适用于经历过其他心脏手术的症状性房颤病人;挑选的无症状的经历心脏手术的病人,在这些病人中房颤的危险最小;和先前导管消融尝试失败,或导管消融不适宜的症状性房颤病人。

“We felt it was important to develop these guidelines so that patients in every corner of the world can receive the highest quality of care available,” commented Task Force member and president-elect of the EHRA Josep Brugada, from the University of Barcelona, Spain.
调查单位的成员,,欧洲心律协会的会长,来自西班牙巴塞罗那大学的Josep Brugada 评论到:“我们觉得制定这些指南很重要,这样的话来自世界每一个角落的病人才能接受高质量的治疗”。
Heart Rhythm Society Annual Scientific Sessions; Denver, Colorado: 9-12 May 2007;
2007年5月9-12日,科罗拉多省丹佛市,心律分会年度科学会议
>

编译:
房颤导管和外科消融的新指南公布
MedWire新闻:在科罗拉多州丹佛市举行的第28界美国心脏节律协会(HRS)年会上,科学家们发布了第一个国际性一致同意的关于导管和外科消融技术治疗房颤(AF)的声明。这个声明的的目的是为医师综合性回顾房颤治疗的技术,以便于改善病人的治疗。研究显示四分之三的房颤病人接受了不适宜的治疗。心脏节律协会医学科学和临床指南委员会主席,来自美国马里兰州Baltimore市Johns Hopkins医院的Hugh Calkins说到:“这些指南是帮助医师为全球范围内的心脏病人提供更好,更安全,更适宜的治疗”。心脏节律协会召集了包括代表美国心脏协会的国际心律专家,欧洲心律协会,欧洲心律失常分会和心脏节律协会心胸外科分会等调查单位共同发表了以上声明。这个声明强调:因为房颤消融比其他消融过程更复杂,所以训练必须包含6个基本原则:合适病人的选择;心房及其邻近解剖结构的知识;房颤消融策略的概念上的知识;能胜任的技术;识别,预防和处理并发症;适当的随访和长期管理。房颤导管消融的基本适应症是存在难治性房颤的症状,或者至少对一种第1类或第3类抗心律失常药耐药,同时,房颤导管消融也适用于心衰和/或射血分数降低的选择性症状性病人。而外科房颤消融适用于经历过其他心脏手术的症状性房颤病人;挑选的无症状的经历心脏手术的病人,在这些病人中房颤的危险最小;和先前导管消融尝试失败,或导管消融不适宜的症状性房颤病人。调查单位的成员,,欧洲心律协会的会长,来自西班牙巴塞罗那大学的Josep Brugada 评论到:“我们觉得制定这些指南很重要,这样的话来自世界每一个角落的病人才能接受高质量的治疗”。

PS:
Task Force我翻译为调查单位,不知对否?

您的位置:医学教育网 >> 医学资料